Immunotherapy for Cancer Patients With Poor PS Needs a Rethink Immunotherapy for Cancer Patients With Poor PS Needs a Rethink

Use of check point inhibitors for patients with advanced cancer who have poor performance status (PS) needs a rethink, says editorialists.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news